|
I am going to be a guinea pig.
|
Most cancer patients report having had a positive experience on a clinical trial and feel that they have been treated with respect.
|
|
I may receive a placebo or a sugar pill instead of treatment in a clinical trial.
|
Placebos (also called sugar pills) are rarely used in cancer clinical trials and are never used in place of treatment.
Patients who join cancer clinical trials are either given the standard of care, (best treatment available for their specific cancer) or receive a new treatment being investigated.
|
|
I will receive inferior medical treatment in a clinical trial.
|
Patients in clinical trials are very closely monitored and may have more frequent exams or tests than usual.
|
|
My health insurance won’t cover the cost of a clinical trial.
|
Medicare and some insurance plans now cover or reimburse patient’s for routine costs such as office visits and tests. Other costs not covered by insurance may be absorbed by the study center.
|
|
I may not be informed of all the risks associated with a clinical trial.
|
All of the risks of a clinical trial are clearly stated and reviewed during the informed consent process as governed by state and federal law.
|
|
I won’t be able to withdraw from a clinical trial without jeopardizing my treatment.
|
Clinical trial participation is voluntary and you can withdraw from a trial at any time.
|
|
Clinical trials are not safe. I don’t want to take the risk.
|
New treatments are tested on human subjects only after there is valid scientific evidence that the treatments are likely to be effective and safe.
|
|
You should only agree to take part in a clinical trial if your cancer is terminal or there are no other treatment options available outside a trial.
|
Some clinical trials are reserved for cancer patients who have exhausted all the treatment options for their disease. But clinical trials of various types are open to patients at all stages of treatment. There are clinical trials that test ways of preventing a recurrence in breast cancer survivors, trials that look at cancer prevention in high-risk populations, and trials that compare different doses of chemotherapy drugs already in use.
|
